Anti-C1s monoclonal antibody BIVV009 in late antibody-mediated kidney allograft rejection-results from a first-in-patient phase 1 trial-Reference-Cited by-同舟云学术

Anti-C1s monoclonal antibody BIVV009 in late antibody-mediated kidney allograft rejection-results from a first-in-patient phase 1 trial

Published:2017-10-31 Issue:4 Volume:18 Page:916-926
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:Am J Transplant

Author:

Eskandary F.¹,Jilma B.²,Mühlbacher J.³,Wahrmann M.¹,Regele H.⁴,Kozakowski N.⁴,Firbas C.²,Panicker S.⁵,Parry G. C.⁵,Gilbert J. C.⁶,Halloran P. F.⁷^ORCID,Böhmig G. A.¹

Affiliation:

1. Division of Nephrology and Dialysis; Department of Medicine III; Medical University of Vienna; Vienna Austria

2. Department of Clinical Pharmacology; Medical University of Vienna; Vienna Austria

3. Department of Surgery; Medical University of Vienna; Vienna Austria

4. Department of Pathology; Medical University of Vienna; Vienna Austria

5. Bioverativ Therapeutics, Inc; South San Francisco CA USA

6. True North Therapeutics, Inc; South San Francisco CA USA

7. Alberta Transplant Applied Genomics Centre; ATAGC; University of Alberta; Edmonton AB Canada

Funder

True North Therapeutics Inc

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ajt.14528/fullpdf

Reference32 articles.

1. The role of complement in antibody-mediated rejection in kidney transplantation;Stegall;Nat Rev Nephrol,2012

2. Mechanisms of rejection: role of complement;Farrar;Curr Opin Organ Transplant,2014

3. A systematic review of the role of C4d in the diagnosis of acute antibody-mediated rejection;Sapir-Pichhadze;Kidney Int,2014

4. Capillary C4d and kidney allograft outcome in relation to morphologic lesions suggestive of antibody-mediated rejection;Kikic;Clin J Am Soc Nephrol,2015

5. Complement-binding anti-HLA antibodies and kidney-allograft survival;Loupy;N Engl J Med,2013

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic Rejection After Kidney Transplantation;Transplantation;2024-08-28

2. Pharmacokinetics, pharmacodynamics, safety, and tolerability of a single-dose riliprubart, an anti-C1s humanized monoclonal antibody in East-Asian adults: results from a Phase 1, randomized, open-label trial;Expert Opinion on Investigational Drugs;2024-08-22

3. Donor-Derived Cell-Free DNA as a Companion Biomarker for AMR Treatment With Daratumumab: Case Series;Transplant International;2024-08-01

4. New Therapies for Highly Sensitized Patients on the Waiting List;Kidney360;2024-07-12

5. A Randomized Phase 2 Trial of Felzartamab in Antibody-Mediated Rejection;New England Journal of Medicine;2024-07-11